Dr. Hyunhwa Kim, Medical Director of NEWVE Clinic in Gangnam, Seoul, South Korea, has been appointed as a Korean Key Opinion Leader (KOL) for AdvaLight Korea. On September 30, 2026, Dr. Kim attended a clinical and technical exchange with AdvaLight Denmark representatives and Korean medical KOLs at Hotel Samjung in Gangnam, Seoul.
AdvaLight Korea KOL meeting: key facts
- Date: September 30, 2026
- Venue: Hotel Samjung, Gangnam, Seoul, South Korea
- Organizer: AdvaLight Korea
- Clinical focus: melasma, facial redness, vascular skin conditions and pigmentation treatment
The meeting brought together the AdvaLight Denmark team, AdvaLight Korea and Korean clinical advisors to discuss the clinical use of the AdvaTx laser, share experience from medical practice and exchange views on future technology development.
Key participants
- Jesper Liltorp Mortensen, PhD: Co-Founder & Vice President of Product Engineering, AdvaLight; co-inventor of the AdvaTx laser and lead for product development
- Anders Bjerg: Executive Vice President, International Sales, AdvaLight
- Doohee Oh: Representative of AdvaLight Korea
- Dr. Hyunhwa Kim: Medical Director of NEWVE Clinic, together with other Korean medical KOLs and clinical advisors
What does a medical-device KOL do?
A Key Opinion Leader (KOL) is a clinician who contributes specialist knowledge and experience from medical practice to discussions about a medical device and its clinical applications. This can include sharing observations on treatment responses, protocols, device usability and potential improvements.
KOLs can also help connect the technical perspectives of device engineers with the practical needs of clinicians. Following this appointment, Dr. Kim is expected to contribute experience in melasma, facial redness and pigmentation care to future advisory discussions about AdvaTx laser applications and technology development.
AdvaTx laser: 589 nm and 1319 nm wavelengths
AdvaTx, also referred to in Korea as the Adva laser or AdvaTX laser, is an AdvaLight dual-wavelength laser system using 589 nm and 1319 nm. The 589 nm wavelength targets hemoglobin for vascular applications, while the 1319 nm wavelength produces dermal thermal effects through water absorption.
Melasma is a complex pigmentation condition. In addition to increased melanin, vascular changes, dermal photoaging and changes to the basement membrane can be involved. When melasma and facial redness occur together, assessment should consider both pigment and vascular features, as well as the overall condition of the skin.
Treatment suitability must be assessed individually. The use of AdvaTx for melasma should be considered carefully in light of clinical evidence and each patient’s condition. This appointment and meeting are not a guarantee of treatment effectiveness or individual results.
Continuing clinical and technical exchange
At NEWVE Clinic, Dr. Kim provides laser care for concerns including solar lentigines, freckles, melasma and facial redness. Clinical experience with REEPOT, ruby, picosecond and vascular lasers informs an approach that considers the characteristics of each lesion and the patient’s skin condition.
The September 30 meeting connected device-development expertise with experience from clinical practice. Dr. Kim plans to continue academic and technical exchange with clinicians and medical-device specialists in Korea and internationally, drawing on experience in pigmentation, melasma and facial redness care.
Frequently asked questions
Is Dr. Hyunhwa Kim an AdvaLight Korea KOL?
Yes. Dr. Hyunhwa Kim, Medical Director of NEWVE Clinic in Gangnam, Seoul, has been appointed as a Korean KOL for AdvaLight Korea and attended its September 30, 2026 clinical and technical exchange.
Are the Adva laser and AdvaTx the same device?
In Korea, the names “Adva laser” and “AdvaTX laser” generally refer to AdvaLight’s AdvaTx system. It uses 589 nm and 1319 nm wavelengths. The suitability of any treatment depends on the individual skin condition and clinical assessment.
When and where was the AdvaLight Korea meeting held?
The meeting was held on September 30, 2026, at Hotel Samjung in Gangnam, Seoul, South Korea. AdvaLight Korea organized the exchange with AdvaLight Denmark representatives and Korean medical KOLs.
More from NEWVE Clinic
About Dr. Hyunhwa Kim and NEWVE Clinic · Pigmentation treatments · Melasma and skin aging care
English adaptation of the official NEWVE Clinic Korean announcement. Photographs: NEWVE Clinic. This article reports professional activities and provides general information, not individualized medical advice.